Hypothalamic-Modified New Hippocampal Neurons for Alzheimer’s Disease  

作　　者：Yan Gu Shaoyu Ge 

机构地区：[1]Center of Stem Cell and Regenerative Medicine,and Department of Neurology of the Second Affiliated Hospital,NHC and CAMS Key Laboratory of Medical Neurobiology,Zhejiang University School of Medicine,Hangzhou,310058,China [2]MOE Frontier Science Center for Brain Science and Brain-Machine Integration,Zhejiang University,Hangzhou,310058,China [3]Department of Neurobiology and Behavior,SUNY Stony Brook,Stony Brook,NY,11794,USA

出　　处：《Neuroscience Bulletin》2023年第11期1735-1737,共3页神经科学通报（英文版）

基　　金：supported by the National Natural Science Foundation of China(32071021 and 32225021);the MOE Frontier Science Center for Brain Science&Brain-Machine Integration,Zhejiang University.

摘　　要：Alzheimer's disease(AD)is the leading cause of dementia worldwide.Although its pathology has been extensively studied,treatment options for AD remain limited.Any option to enhance the plasticity in the degenerating brain renders a potential treatment pathway for AD.

关 键 词：ALZHEIMER PATHOLOGY treatment 

分 类 号：R749.16[医药卫生—神经病学与精神病学]